Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients

Maintaining the balance between eliciting immune responses against foreign proteins and tolerating self-proteins is crucial for maintenance of homeostasis. The functions of programmed death protein 1 (PD-1) and its ligand programmed death ligand 1 (PD-L1) are to inhibit immune responses so that over...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Sunny, Chatterjee, Mouli, Ghosh, Pratyasha, Ganguly, Kirat K., Basu, Malini, Ghosh, Mrinal K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chongqing Medical University 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311058/
https://www.ncbi.nlm.nih.gov/pubmed/37397537
http://dx.doi.org/10.1016/j.gendis.2022.07.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311058/
https://www.ncbi.nlm.nih.gov/pubmed/37397537
http://dx.doi.org/10.1016/j.gendis.2022.07.024

Ejemplares similares